The royalty will not be appllicable, provided the current Directors take up their 25M rights. Which they will. The 11M options are a lifeline for the company. 11M options = 11M dollars. The company needs 45M to get to commercialisation. It will get this, and more in the upcoming raise. STK have likely done very well out of this transaction, but they have provided a lot to Aegros in the companies restructure.
after this raise we are looking at 120M shares on issue. Relatively speaking, this is still quite a low number. Capital to get this up and operating has to come from somewhere!
I took up my full allocation in the latest round, and hope to see fruit of this investment within the next 12-24 months. That is a timeline that I am okay with.
